A Proof of Concept Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on Olaparib in Ovarian Cancer
Phase of Trial: Phase II
Latest Information Update: 05 May 2017
At a glance
- Drugs Cediranib (Primary) ; Olaparib (Primary)
- Indications Ovarian cancer
- Focus Proof of concept; Therapeutic Use
- Acronyms e-Volve
- 07 Jun 2017 Biomarkers information updated
- 16 Jun 2015 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 16 Jun 2015 Planned primary completion date changed from 1 Jan 2017 to 1 Jun 2017 as reported by ClinicalTrials.gov.